CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 34 filers reported holding CYTOSORBENTS CORP in Q3 2015. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $393,000 | +67.9% | 30,500 | +48.8% | 0.00% | – |
| Q2 2018 | $234,000 | +70.8% | 20,500 | +5.1% | 0.00% | – |
| Q1 2018 | $137,000 | +39.8% | 19,500 | +30.0% | 0.00% | – |
| Q4 2017 | $98,000 | -21.0% | 15,000 | -25.0% | 0.00% | – |
| Q3 2017 | $124,000 | -23.9% | 20,000 | -47.4% | 0.00% | – |
| Q2 2017 | $163,000 | +132.9% | 38,000 | +145.2% | 0.00% | – |
| Q1 2017 | $70,000 | +27.3% | 15,500 | +55.0% | 0.00% | – |
| Q4 2016 | $55,000 | -14.1% | 10,000 | 0.0% | 0.00% | – |
| Q3 2016 | $64,000 | +39.1% | 10,000 | -2.0% | 0.00% | – |
| Q2 2016 | $46,000 | +53.3% | 10,200 | +32.5% | 0.00% | – |
| Q1 2016 | $30,000 | +15.4% | 7,700 | +63.8% | 0.00% | – |
| Q4 2015 | $26,000 | +2500.0% | 4,700 | +2250.0% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | -66.7% | 200 | 0.0% | 0.00% | – |
| Q1 2015 | $3,000 | +200.0% | 200 | +100.0% | 0.00% | – |
| Q4 2014 | $1,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 692,738 | $5,524,000 | 2.01% |
| Skylands Capital, LLC | 1,421,700 | $11,345,000 | 1.89% |
| SECTORAL ASSET MANAGEMENT INC | 1,629,989 | $12,999,000 | 1.12% |
| Winning Points Advisors, LLC | 286,200 | $1,142,990,000 | 0.97% |
| Redmile Group, LLC | 2,101,131 | $16,757,000 | 0.31% |
| Granahan Investment Management | 632,035 | $5,040,000 | 0.17% |
| Avenir Corp | 190,240 | $1,517,000 | 0.16% |
| Seelaus Asset Management LLC | 20,000 | $160,000 | 0.13% |
| Olympiad Research LP | 17,816 | $142,000 | 0.07% |
| HighMark Wealth Management LLC | 10,000 | $80,000 | 0.07% |